Table 1.
Patients (N = 96) | Healthy Controls (N=120) | ||||
---|---|---|---|---|---|
Variables | Mean | SD | Mean | SD | P Value |
Age (y) | 39.78 | 11.48 | 38.12 | 14.51 | .36 |
Sex (Male: Female) | 66: 30 | 81: 39 | .84a | ||
Handedness (Right: Left) | 93: 3 | 119: 1 | .33a | ||
Education (y)b | 11.64 | 2.94 | 11.07 | 3.22 | .22 |
Chlorpromazine equivalents (mg/d)c | 332.95 | 165.06 | |||
Duration of illness (y)d | 15.10 | 10.33 | - | - | |
PANSS-positivee | 13.44 | 5.88 | - | - | |
PANSS-negativee | 20.73 | 6.00 | - | - | |
PANSS-generale | 28.22 | 5.81 | - | - | |
PANSS-totale | 62.39 | 13.11 | - | - | |
FD | 0.049 | 0.038 | 0.046 | 0.027 | .42 |
Note: FD, Framewise Displacements; PANSS, Positive and Negative Syndrome Scale.
a x 2 test.
bData of 76 patients and 111 controls available.
cData of 72 patients available.
dData of 88 patients available.
eData of 64 patients available.